Summary:
Florida Lung & Sleep Associates is conducting a clinical outcomes study to compare the effect of Fluticasone Furoatel Vilanterol inhalation powder 100/25mcg with placebo on survival in subjects with moderate Chronic Obstructive Pulmonary Disease (COPD) and a history of or an increased risk for Cardiovascular Disease.
Qualified Participants Must:
• Be between 40 and 80 years of age
•
Have smoked or be a current smoker
•
Have a cardiac condition or high cholesterol, high blood pressure, diabetes, or peripheral artery disease
Qualified Participants May Receive:
Free Medical Care; Free Treatmnet; Compensated for time and travel